Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients
- 1 January 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 59 (1), 69-75
- https://doi.org/10.1046/j.1523-1755.2001.00467.x
Abstract
Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients.BackgroundWe have previously reported that 1α,25-dihydroxyvitamin D3 [1α,25(OH)2D3] accumulates in the dialysis fluid of uremic patients treated by continuous ambulatory peritoneal dialysis (CAPD). It has been reported that this metabolite regulates the production of cytokines by monocytes/macrophages. Since tumor necrosis factor-α (TNF-α) initiates an inflammatory cascade during peritonitis, the aim of the present study was to investigate the effect of 1α,25(OH)2D3 on the production of TNF-α by human peritoneal macrophages (HPMs).MethodsHPMs were obtained from patients on CAPD. Cells were incubated with various concentrations of 1α,25(OH)2D3, 1α,24(S) dihydroxyvitamin D2 [1α,24(S)(OH)2D2] or 25-hydroxyvitamin D3 (25-OH-D3) for 16 hours. This was followed by lipopolysaccharide (LPS; 1 μg/mL) incubation for 2.5 to 6 hours. TNF-α protein production was determined by enzyme-linked immunosorbent assay. TNF-α mRNA was assayed by the reverse transcriptase-polymerase chain reaction procedure, using internal synthetic mRNA standards for quantitative results.ResultsIncubation of HPMs with 1α,25(OH)2D3 prior to stimulation with LPS dose dependently inhibited the expression of TNF-α on both mRNA and protein levels. Similar results were obtained with the less calcemic vitamin D2 analogue 1α,24(S)(OH)2D2. Incubation of HPMs with 25-OH-D3 also revealed a down-regulation of TNF-α expression. Since this down-regulatory effect was blocked by ketoconazole, it is likely that this effect was caused by the conversion of 25-OH-D3 into 1α,25(OH)2D3 by HPMs.Conclusions1α,25(OH)2D3 has a potent inhibitory effect on the production of TNF-α by LPS-activated HPMs. We hypothesize that 1α,25(OH)2D3 may constitute a regulatory mechanism that, by controlling the intensity of the inflammatory response of the peritoneum, will moderate tissue damage during peritonitisKeywords
This publication has 29 references indexed in Scilit:
- Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3Journal of the American Society of Nephrology, 1995
- Effect of 1,25-Dihydroxyvitamin D on the Immune Activity of Peritoneal Macrophages in Continuous Ambulatory Peritoneal Dialysis PatientsNephron, 1995
- Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3Blood, 1992
- Immunological properties of vitamin D analogues and metabolitesBiochemical Pharmacology, 1992
- Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patientsKidney International, 1991
- VITAMIN D AND HUMAN LEUKAEMIABritish Journal of Haematology, 1989
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.JCI Insight, 1987
- Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 productionCellular Immunology, 1986
- Interactions of 1,25-dihydroxyvitamin D3 and the immune systemMolecular and Cellular Endocrinology, 1985
- Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences of the United States of America, 1981